Schizophrenia Research
Volume 100, Issue 1 , Pages 60-69 , March 2008

The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder

  • Matthew J. Byerly

      Affiliations

    • Department of Psychiatry, The University of Texas Southwestern Medical Center, 6363 Forest Park Rd, Suite 651, Dallas, TX 75235-8828, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Paul A. Nakonezny

      Affiliations

    • Department of Clinical Sciences, Division of Biostatistics, The University of Texas Southwestern Medical Center, 6363 Forest Park Rd, Suite 651, Dallas, TX 75235-8828, USA
    • ,
  • A. John Rush

      Affiliations

    • Department of Clinical Sciences and Psychiatry, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9066, USA

Received 10 September 2007 ,Revised 29 November 2007 ,Accepted 6 December 2007.

References 

  1. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J. Hypertens. 2001;19:335–341
  2. Byerly M, Fisher R, Whatley K, Holland R, Varghese F, Carmody T, et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res. 2005;133:129–133
  3. Byerly MJ, Fisher R, Carmody T, Rush AJ. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. J. Clin. Psychiatry. 2005;66:997–1001
  4. Byerly MJ, Thompson A, Carmody T, Bugno R, Erwin T, Kashner M, et al. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr. Serv. 2007;58:844–847
  5. Diaz E, Levine HB, Sullivan MC, Sernyak MJ, Hawkins KA, Cramer JA, et al. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J. Psychiatry Neurosci. 2001;26:325–329
  6. Diaz E, Neuse E, Sullivan MC, Pearsall HR, Woods SW. Adherence to conventional and atypical antipsychotics after hospital discharge. J. Clin. Psychiatry. 2004;65:354–360
  7. Dolder CR, Lacro JP, Warren KA, Golshan S, Perkins DO, Jeste DV. Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence. J. Clin. Psychopharmacol. 2004;24:404–409
  8. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin. Ther. 1999;21:1074–1090(discussion 1073)
  9. Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JM, Thapa P, et al. A pilot study of barriers to medication adherence in schizophrenia. J. Clin. Psychiatry. 2004;65:211–216
  10. Kampman O, Laippala P, Vaananen J, Koivisto E, Kiviniemi P, Kilkku N, et al. Indicators of medication compliance in first-episode psychosis. Psychiatry Res. 2002;110:39–48
  11. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276
  12. Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics. 1997;53:983–997
  13. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry. 2002;63:892–909
  14. Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann. Intern. Med. 2001;134:968–977
  15. McEvoy JP. CATIE Adherence Questionnaire. Adapted with Permission. 2003;
  16. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care. 1986;24:67–74
  17. Nakonezny PA, Byerly MJ. Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics. Schizophr. Res. 2006;82:107–114
  18. Nakonezny P, Byerly M, Rush AJ. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of its reliability and predictive validity. Psychiatry Res. 2008;157:259–263
  19. Osterberg L, Blaschke T. Adherence to medication. N. Engl. J. Med. 2005;353:487–497
  20. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr. Res. 2000;42:241–247
  21. Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr. Bull. 2006;32:724–742
  22. Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr. Serv. 2004;55:886–891

PII: S0920-9964(07)01036-5

doi: 10.1016/j.schres.2007.12.470

Schizophrenia Research
Volume 100, Issue 1 , Pages 60-69 , March 2008

Article Tools

* Image Usage & Resolution